AAAAAA

   
Results: 1-7 |
Results: 7
3 NEW HIGHLY-ACTIVE CISPLATIN-CONTAINING COMBINATIONS IN LOCALLY-ADVANCED (STAGE-III) AND LOCALLY-RECURRENT BREAST-CARCINOMA - A PHASE-II RANDOMIZED STUDY
Authors: BISAGNI G COCCONI G CECI G DIBLASIO B DELISI V PASSALACQUA R ZADRO A BONI C MORANDI P SAVOLDI L
Citation: G. Bisagni et al., 3 NEW HIGHLY-ACTIVE CISPLATIN-CONTAINING COMBINATIONS IN LOCALLY-ADVANCED (STAGE-III) AND LOCALLY-RECURRENT BREAST-CARCINOMA - A PHASE-II RANDOMIZED STUDY, European journal of cancer, 34, 1998, pp. 79-79
NEOADJUVANT ALTERNATED CHEMORADIOTHERAPY FOR T2-T4 TRANSITIONAL BLADDER-CARCINOMA (TBC)
Authors: PASSALACQUA R LEONARDI F CECI G BIDIN L PAJETTA V BISCARI L POTENZONI D FUMAGALLI M CAMISA R COCCONI G
Citation: R. Passalacqua et al., NEOADJUVANT ALTERNATED CHEMORADIOTHERAPY FOR T2-T4 TRANSITIONAL BLADDER-CARCINOMA (TBC), Annals of oncology, 9, 1998, pp. 275-275
COMPARISON BETWEEN KI-67 INDEX AND S-PHASE FRACTION ON FINE-NEEDLE ASPIRATION SAMPLES FROM BREAST-CARCINOMA
Authors: BOZZETTI C NIZZOLI R CAMISA R GUAZZI A CECI G COCCONI G MAZZINI G NALDI N
Citation: C. Bozzetti et al., COMPARISON BETWEEN KI-67 INDEX AND S-PHASE FRACTION ON FINE-NEEDLE ASPIRATION SAMPLES FROM BREAST-CARCINOMA, Cancer cytopathology, 81(5), 1997, pp. 287-292
CHEMOTHERAPY OF ADVANCED NON-SMALL-CELL LUNG-CANCER - A COMPARISON OF3 ACTIVE REGIMENS - A RANDOMIZED TRIAL OF THE ITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCH (GOIRC)
Authors: CRINO L CLERICI M FIGOLI F CARLINI P CECI G CORTESI E CARPI A SANTINI A DICOSTANZO F BONI C MEACCI M CORGNA E DARWISH S SCARCELLA L SANTUCCI A BALLATORI E
Citation: L. Crino et al., CHEMOTHERAPY OF ADVANCED NON-SMALL-CELL LUNG-CANCER - A COMPARISON OF3 ACTIVE REGIMENS - A RANDOMIZED TRIAL OF THE ITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCH (GOIRC), Annals of oncology, 6(4), 1995, pp. 347-353
CISPLATIN AND VP16 IN METASTATIC BREAST-CARCINOMA AS A 3RD-LINE CHEMOTHERAPY - A RANDOMIZED STUDY COMPARING LOW VERSUS HIGH-DOSES OF CISPLATIN
Authors: CECI G BISAGNI G COCCONI G RODINO C BELSANTI V BERTUSI M BUZZI F BACCHI M
Citation: G. Ceci et al., CISPLATIN AND VP16 IN METASTATIC BREAST-CARCINOMA AS A 3RD-LINE CHEMOTHERAPY - A RANDOMIZED STUDY COMPARING LOW VERSUS HIGH-DOSES OF CISPLATIN, Tumori, 81(4), 1995, pp. 241-244
SUPERIORITY OF 3-DRUG COMBINATION CHEMOTHERAPY VERSUS CISPLATIN-ETOPOSIDE IN ADVANCED NONSMALL CELL LUNG-CANCER - A RANDOMIZED TRIAL BY THEITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCH
Authors: CRINO L CLERICI M FIGOLI F BARDUAGNI M CARLINI P CECI G CORTESI E CARPI A SANTINI A DICOSTANZO F BONI C MEACCI M CORGNA E SANTUCCI A BALLATORI E TONATO M
Citation: L. Crino et al., SUPERIORITY OF 3-DRUG COMBINATION CHEMOTHERAPY VERSUS CISPLATIN-ETOPOSIDE IN ADVANCED NONSMALL CELL LUNG-CANCER - A RANDOMIZED TRIAL BY THEITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCH, Lung cancer, 12, 1995, pp. 125-132
M-VAC COMBINATION IN LOCALLY ADVANCED, LOCALLY RECURRENT OR METASTATIC BREAST-CARCINOMA - A PHASE-II STUDY
Authors: BISAGNI G COCCONI G CECI G DELISI V DIBLASIO B LOTTICI R PASSALACQUA R FINARDI C
Citation: G. Bisagni et al., M-VAC COMBINATION IN LOCALLY ADVANCED, LOCALLY RECURRENT OR METASTATIC BREAST-CARCINOMA - A PHASE-II STUDY, Annals of oncology, 5(1), 1994, pp. 93-94
Risultati: 1-7 |